Boundless Bio, Inc. (BOLD)
Nasdaq: BOLD · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2020
Filings
86 filings since 2017 beside 78 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 28, 2026.
Filings a yearinsider forms included
115723352
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Jun 23, 2026.SEC letters: 10 in the last 36 months, the newest Apr 8, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jun 23, 2026
8-K items 1.01, 2.05, 3.02, 5.01, 5.02, 7.01, 8.01, 9.01
Major agreement signed; Exit or restructuring costs; Shares sold without registration; Change of control; Officer or director change; Investor disclosure (Regulation FD); Other event · Current report
Jun 22, 2026
Apr 13, 2026
8-K items 1.02, 2.03
Major agreement ended; New debt or obligation taken on · Current report
Mar 9, 2026
8-K items 2.02, 5.02, 9.01
Results released; Officer or director change · Current report
Mar 3, 2026
40 of 86 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.